08048036315
Transplant TAKFA 1mg Capsules trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

TAKFA 1 mg Capsules are an immunosuppressive medicine containing Tacrolimus 1 mg. Tacrolimus reduces certain immune-system responses that can cause the body to attack a transplanted organ. It is generally prescribed as part of a combination immunosuppressive regimen following organ transplantation.

Tacrolimus requires careful medical supervision because excessive immunosuppression can increase the risk of serious infections and certain malignancies.

2. Product Information

  • Brand: TAKFA 1 mg
  • Active ingredient: Tacrolimus
  • Strength: 1 mg
  • Dosage form: Capsules
  • Therapeutic class: Immunosuppressant
  • Pharmacological class: Calcineurin inhibitor
  • Route: Oral
  • Marketer: Intas Pharmaceuticals Ltd.
  • Typical pack: 10 capsules per strip
  • Storage: Store below 25°C, according to the product information.
  • Prescription status: Prescription medicine.

3. Uses of TAKFA 1 mg

TAKFA 1 mg is used with other immunosuppressive medicines to help prevent organ rejection following transplantation. Tacrolimus capsules are indicated for rejection prophylaxis in patients receiving allogeneic kidney, liver, or heart transplants, depending on the applicable product labeling and patient population.

It may therefore be prescribed as part of a long-term transplant-management regimen under the supervision of a transplant specialist.

4. Benefits of This Medicine

The principal benefit of TAKFA 1 mg is its ability to suppress specific immune-system activity that could otherwise attack a transplanted organ.

Potential therapeutic benefits include:

  • Helps reduce the risk of transplant rejection.
  • Supports continued acceptance and function of the transplanted organ.
  • Can form an important component of combination immunosuppressive therapy.
  • Provides targeted calcineurin inhibition to reduce T-cell-mediated immune activity.

Important: The medicine does not cure the underlying reason for transplantation and should not be stopped without medical advice.

5. Side Effects of TAKFA 1 mg

Tacrolimus can cause side effects, and the risk can vary according to dose, blood concentration, other medicines, and the patient's medical condition.

Important potential adverse effects include:

  • Kidney problems
  • Increased blood glucose or diabetes
  • High blood pressure
  • Tremor
  • Headache
  • Insomnia
  • Nausea or diarrhea
  • Increased susceptibility to infections
  • Electrolyte abnormalities
  • Neurological effects

Tacrolimus can also cause serious adverse effects requiring medical monitoring, including kidney toxicity, significant infections, and increased risk of certain malignancies.

6. Common Side Effects

Some commonly reported effects associated with tacrolimus include:

  • Tremors
  • Headache
  • Diarrhea
  • Nausea
  • Difficulty sleeping
  • Increased blood sugar
  • Increased blood pressure
  • Increased susceptibility to infections

If symptoms are persistent, severe, or unusual, the patient should contact their treating physician.

7. How to Use TAKFA 1 mg

TAKFA 1 mg should be taken exactly according to the transplant specialist's prescription. The required dose varies between patients according to factors such as the transplanted organ, body weight, other medicines, and tacrolimus blood concentrations.

General administration principles include:

  1. Take the capsule at the prescribed time every day.
  2. Swallow the capsule whole with water.
  3. Take it consistently either with food or without food; changing the way it is taken can alter absorption.
  4. Do not change the dose or discontinue treatment without consulting the transplant team.
  5. Tacrolimus blood-level monitoring is generally required to help maintain an appropriate therapeutic concentration.

8. How TAKFA 1 mg Works

Tacrolimus works by inhibiting calcineurin, an enzyme involved in activation of T lymphocytes. This reduces the production of certain immune-signaling substances and suppresses the immune response.

As a result, the immune system is less likely to attack and reject a transplanted organ. Tacrolimus is therefore classified as a calcineurin-inhibitor immunosuppressant.

9. Safety Advice

TAKFA 1 mg requires careful medical supervision.

Important safety considerations:

  • Prescription only: Use only under the supervision of an experienced transplant physician.
  • Infection risk: Tacrolimus suppresses the immune system and can increase susceptibility to bacterial, viral, fungal, and other infections.
  • Cancer risk: Long-term immunosuppression is associated with an increased risk of lymphoma and certain other malignancies, including skin cancers.
  • Kidney monitoring: Kidney function should be monitored because tacrolimus can affect renal function.
  • Blood tests: Regular monitoring of tacrolimus concentrations and relevant laboratory parameters is important.
  • Blood pressure and glucose: These may require monitoring during treatment.
  • Drug interactions: Tell your doctor about all prescription medicines, OTC medicines, supplements, and herbal products before starting or changing treatment.
  • Food consistency: Take it consistently with or without food as instructed.
  • Do not stop suddenly: Missing doses or stopping tacrolimus without medical advice can increase the risk of transplant rejection.
  • Pregnancy/breastfeeding: Discuss pregnancy, planned pregnancy, or breastfeeding with the treating specialist before using tacrolimus.

10. Frequently Asked Questions (FAQs)

Q1. What is TAKFA 1 mg used for?
TAKFA 1 mg contains tacrolimus and is primarily used with other immunosuppressive medicines to prevent rejection of transplanted organs.

Q2. What is the active ingredient in TAKFA 1 mg?
The active ingredient is Tacrolimus 1 mg.

Q3. Is TAKFA 1 mg a prescription medicine?
Yes. Tacrolimus is a prescription immunosuppressant requiring specialist medical supervision.

Q4. Can I stop TAKFA 1 mg if I feel well?
No. Transplant patients should not stop or change tacrolimus treatment without instructions from their transplant specialist because this can increase the risk of organ rejection.

Q5. Does TAKFA 1 mg require blood tests?
Yes. Tacrolimus therapy generally requires therapeutic drug monitoring along with monitoring of kidney function and other relevant laboratory parameters.

Q6. What are common side effects?
Tremor, headache, diarrhea, nausea, insomnia, increased blood sugar, high blood pressure, and infections can occur.

Q7. Can TAKFA 1 mg interact with other medicines?
Yes. Tacrolimus has clinically important drug interactions. Patients should provide their doctor or pharmacist with a complete list of medicines and supplements they use.

Q8. How should TAKFA 1 mg be stored?
The product information available for TAKFA 1 mg states storage below 25°C.

11. Substitutes for TAKFA 1 mg

Possible alternatives may contain the same active ingredient, Tacrolimus 1 mg, but the exact product, formulation, manufacturer, and availability can differ between markets.

Examples of tacrolimus products include:

  • Tacrolimus 1 mg Capsules
  • Generic Tacrolimus 1 mg Capsules
  • Other branded Tacrolimus 1 mg preparations

Do not substitute TAKFA with another tacrolimus product on your own. Tacrolimus has a narrow therapeutic range, and changing products or formulations may require additional monitoring and physician guidance.

12. SEO Keywords

  • TAKFA 1 mg Capsules
  • TAKFA 1 mg Tacrolimus Capsules
  • Tacrolimus 1 mg Capsules exporter from India
  • TAKFA 1 mg exporter from Nagpur India
  • Tacrolimus 1 mg medicine exporter India
  • TAKFA 1 mg pharmaceutical exporter
  • TAKFA 1 mg Capsules supplier India
  • Tacrolimus 1 mg Capsules wholesale supplier
  • TAKFA 1 mg Capsules international supplier
  • Tacrolimus Capsules export from India
  • TAKFA 1 mg Capsules for transplant patients
  • Tacrolimus 1 mg organ transplant medicine
  • Tacrolimus immunosuppressant Capsules
  • TAKFA 1 mg Capsules supplier to USA
  • TAKFA 1 mg Capsules supplier to UK
  • TAKFA 1 mg Capsules supplier to Australia
  • TAKFA 1 mg Capsules supplier to Singapore
  • TAKFA 1 mg Capsules supplier to Canada
  • TAKFA 1 mg Capsules supplier to South Korea
  • TAKFA 1 mg Capsules supplier to UAE
  • Tacrolimus 1 mg exporter to USA UK Australia
  • Tacrolimus 1 mg exporter to Canada Singapore UAE
  • Genuine TAKFA 1 mg Capsules supplier
  • Pharmaceutical medicine exporter from Nagpur
  • Tacrolimus 1 mg wholesale pharmaceutical supplier


Aug 21st, 2026 3:18 PM

Keywords